Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
德里一项针对新冠肺炎住院患者的螺内酯联合地塞米松与单用地塞米松的二期随机安慰剂对照试验
期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-023-08286-w
Wadhwa, Bharti; Malhotra, Vikas; Kerai, Sukhyanti; Husain, Farah; Pandey, Nalini Bala; Saxena, Kirti N; Singh, Vinay; Quinn, Tom M; Li, Feng; Gaughan, Erin; Shankar-Hari, Manu; Mills, Bethany; Antonelli, Jean; Bruce, Annya; Finlayson, Keith; Moore, Anne; Dhaliwal, Kevin; Edwards, Christopher
